FDA.reportPublic FDA data

Application 091072

Type
ANDA
Sponsor
APOTEX INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 1.5MG BASENoNo
002RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 3MG BASENoNo
003RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 4.5MG BASENoNo
004RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATECAPSULE;ORALEQ 6MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
60429-393Rivastigmine TartrateRivastigmine TartrateGolden State Medical Supply, Inc.ANDACurrent
60429-394Rivastigmine TartrateRivastigmine TartrateGolden State Medical Supply, Inc.ANDACurrent
60429-395Rivastigmine TartrateRivastigmine TartrateGolden State Medical Supply, Inc.ANDACurrent
60429-396Rivastigmine TartrateRivastigmine TartrateGolden State Medical Supply, Inc.ANDACurrent
60505-3220Rivastigmine TartrateRivastigmine TartrateApotex Corp.ANDACurrent
60505-3221Rivastigmine TartrateRivastigmine TartrateApotex Corp.ANDACurrent
60505-3222Rivastigmine TartrateRivastigmine TartrateApotex Corp.ANDACurrent
60505-3223Rivastigmine TartrateRivastigmine TartrateApotex Corp.ANDACurrent